Search:

Biotechnology Headlines from PR Newswire


< Go Back

3SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement
Vanda Pharmaceuticals Named the 2013 Life Science Firm of the Year by the Tech Council of Maryland
Venaxis Announces Pricing of Offering of Common Stock and Warrants
BioScrip To Present At Jefferies 2013 Global Healthcare Conference
Hadasit Bio-Holdings Ltd. Portfolio Company - Cell Cure Neurosciences Ltd. Received Additional Government Support
StemCyte, Inc. Joins Rahal Letterman Lanigan Racing As Associate Sponsor Of No. 16 IndyCar Program For James Jakes Beginning With The 97th Indianapolis 500
MGC Diagnostics Corporation to Report Second Quarter Fiscal 2013 Financial Results on Thursday, May 30, 2013
Echo Therapeutics Announces Successful Unveiling of Symphony® CGM System
PuraMed BioScience (PMBS) Issued Alert Based on Market Cap of $721,756
Saddleback Memorial Surgeon First on the West Coast to Perform Single-Site Robotic Hysterectomy
VG Energy Enters into a Strategic Alliance with DAK Renewable Research for LipidMax Field Trials
Spring Bank Pharmaceuticals Initiates a Phase I Clinical Trial for SB 9200 in HCV-infected Patients
The Majority of Physicians that Treat Hepatitis C Virus (HCV) Have Begun "Warehousing" and Preparing Their HCV Patients for the Next Generation of HCV Treatments
Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain
Direct to Implant ("One Step") Mastectomy Breast Reconstruction Reduces Number of Surgeries and Time to Final Cosmetic Results
Z Trim's Chef Erin Ryan sits on Expert Panel at NRA Show
Israel Brain Technologies Announces Israel's 1st International Brain Technology Conference
NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer
Intercept Pharmaceuticals to Present at Deutsche Bank Healthcare Conference
Halozyme Therapeutics Names David A. Ramsay Chief Financial Officer
Verenium To Present At Two Upcoming Conferences
Pressure BioSciences, Inc. to Discuss First Quarter 2013 Financial Results and Provide Business Update
Aeterna Zentaris: Posters to be Presented on Phase 1 and Phase 2 Trials with AEZS-108 in Prostate and Breast Cancer at Upcoming ASCO Meeting
Pusan National University Announces Science Translational Medicine Publication Highlighting Landmark Demonstration of Functional Anti-Cancer Antibody Induction in Patients Following JX-594 Treatment
Biorem Reports 3rd Consecutive Quarter with Positive EBITDA
Clinical Team Researching the Impact of the EarlySense System Wins 'Best Novel Idea' Prize at the Rapid Response Systems and Medical Emergency Teams 2013 8th International Conference
OncoGenex Announces Plans for the Initiation of the Cedar™ Clinical Trial Evaluating OGX-427 in Combination with Chemotherapy in Advanced Squamous Cell Lung Cancer
PAREXEL International To Present At Jefferies Healthcare Conference
BioLife Solutions Announces Presentation at 8th World Stem Cells & Regenerative Medicine Congress
InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group
Amgen Announces Voting Results of Annual Meeting of Stockholders
New Clinical Data Presented at EuroPCR Demonstrates that TriGuard Reduces Brain Lesion Volume during TAVR
New Data Demonstrate Significant And Sustained Blood Pressure Reduction With Boston Scientific Vessix™ Renal Denervation System
Three New Health Systems Integrate Hyland Software's OnBase with Meditech Hospital Information System
Boston Scientific Reports Lotus™ Valve System Met Primary Performance Endpoint in REPRISE II Trial
Scientific and Technical Evaluation of Pharmaceuticals, Inc. [STEPh, Inc.], Launches New Competitive Intelligence Web Site
Oligomerix, Inc. Completes Series B Financing
Organogenesis Presents Findings from Groundbreaking Research Highlighting the Healthcare Resource and Economic Burden of Venous Leg Ulcers and Diabetic Foot Ulcers
Boston Scientific Promus PREMIER™ And SYNERGY™ Drug-Eluting Stent Systems Provide Exceptional Safety And Efficacy Data
Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine
Superior Controls of Seabrook, NH named Business of the Year for 2013 by Business NH Magazine
Empire Genomics Licenses Novel DNA Biomarker for Use in Diagnosing and Creating a Companion Diagnostic Test for Neuroendocrine Prostate Cancer
Ohr Pharmaceutical Appoints June S. Almenoff to Board of Directors
Rosetta Genomics to Present at the Jefferies 2013 Healthcare Conference
Cellular Biomedicine Group Announces Enrollment Milestone for Phase I Clinical Trial for Liver Cancer
Can-Fite BioPharma To Present At The Second Annual Marcum LLP MicroCap Conference
Celsion Announces Issuance of Additional Patents Covering ThermoDox® Technologies
Ambit Biosciences Announces Presentations of Data from Clinical Investigations of Quizartinib at the Annual Meeting of the American Society of Clinical Oncology
Cleveland BioLabs to Present at Second Annual Marcum LLP Microcap Conference
Industry Leader John Reynders Joins Moderna Therapeutics as Chief Information Officer

< Prev Next >
PR Newswire - United Business Media